Reaction Details Report a problem with these data
Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM504459
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
>1000±n/a nM
Citation
 Crew, AP; Araujo, E Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides US Patent  US11065231 Publication Date 7/20/2021 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM504459
Synonyms:
4-((1s,4s)-4-(4-((2-(2-(2-(2- ((2-(2,6-dioxopiperidin-3- yl)-1,3-dioxoisoindolin-5- yl)oxy)ethoxy)ethoxy)ethoxy) ethyl)sulfonyl)piperazin-1- yl)cyclohexyl)amino) quinazoline-6-carbonitrile | US11065231, Example 39
Type:
Small organic molecule
Emp. Form.:
C40H48N8O10S
Mol. Mass.:
832.922
SMILES:
O=C1N(C2CCC(=O)NC2=O)C(=O)c2cc(OCCOCCOCCOCCS(=O)(=O)N3CCN(CC3)[C@@H]3CC[C@@H](CC3)Nc3ncnc4ccc(cc34)C#N)ccc12 |r,wU:40.45,37.38,(14.63,1.69,;14.16,.23,;15.06,-1.02,;16.6,-1.02,;17.37,.32,;18.91,.32,;19.68,-1.02,;21.22,-1.02,;18.91,-2.35,;17.37,-2.35,;16.6,-3.68,;14.16,-2.26,;14.63,-3.73,;12.69,-1.79,;11.36,-2.56,;10.03,-1.79,;8.73,-2.56,;7.43,-1.79,;6.13,-2.56,;4.84,-1.79,;3.54,-2.56,;2.24,-1.79,;.94,-2.56,;-.35,-1.79,;-1.65,-2.56,;-2.95,-1.79,;-2.95,-.25,;-4.28,.52,;-4.28,2.06,;-4.28,3.6,;-2.74,2.06,;-5.82,2.06,;-6.59,.73,;-8.13,.73,;-8.9,2.06,;-8.13,3.4,;-6.59,3.4,;-10.44,2.06,;-11.21,3.4,;-12.75,3.4,;-13.52,2.06,;-12.75,.73,;-11.21,.73,;-15.06,2.06,;-15.83,.73,;-15.06,-.6,;-15.83,-1.94,;-17.37,-1.94,;-18.14,-.6,;-19.68,-.6,;-20.45,.73,;-19.68,2.06,;-18.14,2.06,;-17.37,.73,;-20.45,3.4,;-21.22,4.73,;10.03,-.25,;11.36,.52,;12.69,-.25,)|
Structure:
Search PDB for entries with ligand similarity: